Bevin Page Engelward is currently Professor of Biological Engineering and Director of the MIT Superfund Research Program Center
Bevin Page Engelward graduated from Yale University in 1988 and from the Harvard School of Public Health in 1996. She joined the faculty at the Massachusetts Institute of Technology in 1997. The main interests of Prof. Engelward are DNA damage and repair, and development of novel technologies relevant to cancer etiology and drug development. In particular, she leads efforts to exploit photolithography to create cell microarrays that serve as a platform for novel toxicity and genotoxicity assays. In addition to studies of cytotoxicity and genotoxicity, her laboratory was the first to develop a mouse model wherein mutations (caused by homologous recombination) can be detected in situ via fluorescence.